Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Fraser

Showing results (171-180 of 238) with videos related to

Pageof 24
Sort By:
The Journal of Antimicrobial Chemotherapy|February 28, 2020
High prevalence of integrase mutation L74I in West African HIV-1 subtypes prior to integrase inhibitor treatmentKate El Bouzidi, Steven A Kemp, Rawlings P Datir, et al.
The Journal of Antimicrobial Chemotherapy|June 27, 2023
Limited emergence of resistance to integrase strand transfer inhibitors (INSTIs) in ART-experienced participants failing dolutegravir-based antiretroviral therapy: a cross-sectional analysis of a Northeast Nigerian cohortAdam Abdullahi, Ibrahim Musa Kida, Umar Abdullahi Maina, et al.
Plos Pathogens|July 28, 2018
Evolution of HIV-1 within untreated individuals and at the population scale in UgandaJayna Raghwani, Andrew D Redd, Andrew F Longosz, et al.
The Journal of Antimicrobial Chemotherapy|August 11, 2020
Performance of a high-throughput next-generation sequencing method for analysis of HIV drug resistance and viral loadJessica M Fogel, David Bonsall, Vanessa Cummings, et al.
Plos Pathogens|April 22, 2025
Quantifying prevalence and risk factors of HIV multiple infection in Uganda from population-based deep-sequence dataMichael A Martin, Andrea Brizzi, Xiaoyue Xi, et al.
International Journal of Epidemiology|August 12, 2025
Age and gender profiles of HIV infection burden and viraemia: novel metrics for HIV epidemic control in African populations with high antiretroviral therapy coverageAndrea Brizzi, Joseph Kagaayi, Robert Ssekubugu, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2024
Increasing intra- and inter-subtype HIV diversity despite declining HIV incidence in UgandaSeungwon Kim, Godfrey Kigozi, Michael A Martin, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Population dynamics of HIV drug resistance during treatment scale-up in Uganda: a population-based longitudinal studyMichael A Martin, Steven James Reynolds, Brian T Foley, et al.
The Lancet. Microbe|November 30, 2025
HIV drug resistance during antiretroviral therapy scale-up in Uganda, 2012-19: a population-based, longitudinal studyMichael A Martin, Steven James Reynolds, Brian T Foley, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2024
Age and gender profiles of HIV infection burden and viraemia: novel metrics for HIV epidemic control in African populations with high antiretroviral therapy coverageAndrea Brizzi, Joseph Kagaayi, Robert Ssekubugu, et al.
Pageof 24

Showing results (171-180 of 238) with videos related to

Sort By:
Pageof 24
The Journal of Antimicrobial Chemotherapy|February 28, 2020
High prevalence of integrase mutation L74I in West African HIV-1 subtypes prior to integrase inhibitor treatmentKate El Bouzidi, Steven A Kemp, Rawlings P Datir, et al.
The Journal of Antimicrobial Chemotherapy|June 27, 2023
Limited emergence of resistance to integrase strand transfer inhibitors (INSTIs) in ART-experienced participants failing dolutegravir-based antiretroviral therapy: a cross-sectional analysis of a Northeast Nigerian cohortAdam Abdullahi, Ibrahim Musa Kida, Umar Abdullahi Maina, et al.
Plos Pathogens|July 28, 2018
Evolution of HIV-1 within untreated individuals and at the population scale in UgandaJayna Raghwani, Andrew D Redd, Andrew F Longosz, et al.
The Journal of Antimicrobial Chemotherapy|August 11, 2020
Performance of a high-throughput next-generation sequencing method for analysis of HIV drug resistance and viral loadJessica M Fogel, David Bonsall, Vanessa Cummings, et al.
Plos Pathogens|April 22, 2025
Quantifying prevalence and risk factors of HIV multiple infection in Uganda from population-based deep-sequence dataMichael A Martin, Andrea Brizzi, Xiaoyue Xi, et al.
International Journal of Epidemiology|August 12, 2025
Age and gender profiles of HIV infection burden and viraemia: novel metrics for HIV epidemic control in African populations with high antiretroviral therapy coverageAndrea Brizzi, Joseph Kagaayi, Robert Ssekubugu, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2024
Increasing intra- and inter-subtype HIV diversity despite declining HIV incidence in UgandaSeungwon Kim, Godfrey Kigozi, Michael A Martin, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Population dynamics of HIV drug resistance during treatment scale-up in Uganda: a population-based longitudinal studyMichael A Martin, Steven James Reynolds, Brian T Foley, et al.
The Lancet. Microbe|November 30, 2025
HIV drug resistance during antiretroviral therapy scale-up in Uganda, 2012-19: a population-based, longitudinal studyMichael A Martin, Steven James Reynolds, Brian T Foley, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2024
Age and gender profiles of HIV infection burden and viraemia: novel metrics for HIV epidemic control in African populations with high antiretroviral therapy coverageAndrea Brizzi, Joseph Kagaayi, Robert Ssekubugu, et al.
Pageof 24